Key facts
- This page summarizes Florian Brand's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Mar 2024, 20:16.
Florian Brand - 14 Mar 2024 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)
- Reporting relationship
- Co-Founder & Chief Executive Officer
- Issuer ticker
- ATAI
- Reported as of
- 14 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Mar 2024, 20:16:13 UTC
- Prior SEC filing
- 20 Nov 2023
- Next SEC filing
- 20 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Barrett , Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Florian Brand filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 15 Mar 2024.
Change
- Previous filing in this sequence was filed on 20 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATAI
transaction
Common Shares
Options Exercise
- Transaction value
- Shares
- +350,000
- Change %
- +269%
- Price
- Shares after
- 480,000
- Date
- 14 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
ATAI
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,333
- Date
- 14 Mar 2024
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATAI
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -350,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 350,000
- Date
- 14 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 350,000
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.
SEC remarks
Co-Founder & Chief Executive Officer